UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Thalamic atrophy is associated with development of clinically definite multiple sclerosis

Radiology, 2013-09, Vol.268 (3), p.831

2013

Link zum Volltext

Verfügbarkeit prüfen

Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses

Clinical neurophysiology, 2020-05, Vol.131 (5), p.1155-1165

2020

Link zum Volltext

Verfügbarkeit prüfen

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231180719-17562864231180719

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)

Dysphagia, 2023-08, Vol.38 (4), p.1087-1095

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late‐onset Tay‐Sachs disease

Journal of inherited metabolic disease, 2024-03, Vol.47 (2), p.327-339

2024

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

BMC neurology, 2017-07, Vol.17 (1), p.145-145, Article 145

2017

Link zum Volltext

Verfügbarkeit prüfen

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Multiple sclerosis, 2021-04, Vol.27 (5), p.755-766

2021

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

Therapeutic Advances in Neurological Disorders, 2020, Vol.13, p.1756286420975223-1756286420975223

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of multiple sclerosis patients in central European countries: current needs and potential solutions

Therapeutic Advances in Neurological Disorders, 2018-01, Vol.11, p.1756286418759189-1756286418759189

2018

Link zum Volltext

Verfügbarkeit prüfen

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program

Therapeutics and clinical risk management, 2017-01, Vol.13, p.1423-1437

2017

Link zum Volltext

Verfügbarkeit prüfen

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Multiple sclerosis journal - experimental, translational and clinical, 2020-10, Vol.6 (4), p.2055217320972137-2055217320972137

2020

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

Therapeutic Advances in Neurological Disorders, 2015-01, Vol.8 (1), p.31-45

2015

Link zum Volltext

Verfügbarkeit prüfen

Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

Multiple sclerosis, 2021-02, Vol.27 (2), p.220-231

2021

Link zum Volltext

Verfügbarkeit prüfen

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

PloS one, 2012-11, Vol.7 (11), p.e50101-e50101

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis

Multiple sclerosis, 2021-01, Vol.27 (1), p.52-60

2021

Link zum Volltext

Verfügbarkeit prüfen

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

Journal of lipid research, 2017-02, Vol.58 (2), p.403-411

2017

Link zum Volltext

Verfügbarkeit prüfen

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Brain (London, England : 1878), 2017-09, Vol.140 (9), p.2426-2443

2017

Link zum Volltext

Verfügbarkeit prüfen

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

Multiple sclerosis, 2021-11, Vol.27 (13), p.2001-2013

2021

Link zum Volltext

Verfügbarkeit prüfen

Mucosal Immunity: Its Role in Defense and Allergy

International archives of allergy and immunology, 2002-06, Vol.128 (2), p.77-89

2002

Link zum Volltext

Verfügbarkeit prüfen

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

Multiple sclerosis, 2019-04, Vol.25 (4), p.541-553

2019

Link zum Volltext

Verfügbarkeit prüfen

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS

International journal of molecular sciences, 2023-06, Vol.24 (12), p.10048

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(170)

Publikationsform

Artikel
(188)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(159)
Multiple Sclerosis
(134)
Neurosciences & Neurology
(129)
Clinical Neurology
(112)
Humans
(109)
Neurosciences
(75)
Female
(72)
Adult
(67)
Male
(64)
Magnetic Resonance Imaging
(48)
Disease Progression
(39)
Middle Aged
(39)
Neurology
(32)
Multiple Sclerosis - Drug Therapy
(31)
Atrophy
(28)
Mri
(28)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(27)
Recurrence
(27)
Patients
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Thalamic atrophy is associated with development of clinically definite multiple sclerosis

Characterizing vocal tremor in progressive neurological diseases via automated acoustic analyses

Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis

Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)

International consensus on quality standards for brain health-focused care in multiple sclerosis

Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late‐onset Tay‐Sachs disease

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

Management of multiple sclerosis patients in central European countries: current needs and potential solutions

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS

Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis

Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

Mucosal Immunity: Its Role in Defense and Allergy

Pathological cut-offs of global and regional brain volume loss in multiple sclerosis

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS

Suchergebnisse filtern